BRTX
Price
$1.25
Change
-$0.13 (-9.42%)
Updated
Nov 13, 04:58 PM (EDT)
Capitalization
11.01M
133 days until earnings call
Intraday BUY SELL Signals
KYMR
Price
$63.61
Change
+$0.08 (+0.13%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
4.57B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BRTX vs KYMR

Header iconBRTX vs KYMR Comparison
Open Charts BRTX vs KYMRBanner chart's image
BioRestorative Therapies
Price$1.25
Change-$0.13 (-9.42%)
Volume$1.85K
Capitalization11.01M
Kymera Therapeutics
Price$63.61
Change+$0.08 (+0.13%)
Volume$18.72K
Capitalization4.57B
BRTX vs KYMR Comparison Chart in %
View a ticker or compare two or three
VS
BRTX vs. KYMR commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRTX is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BRTX: $1.38 vs. KYMR: $63.53)
Brand notoriety: BRTX and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRTX: 24% vs. KYMR: 115%
Market capitalization -- BRTX: $11.01M vs. KYMR: $4.57B
BRTX [@Biotechnology] is valued at $11.01M. KYMR’s [@Biotechnology] market capitalization is $4.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRTX’s FA Score shows that 1 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • BRTX’s FA Score: 1 green, 4 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, both BRTX and KYMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRTX’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 3 bullish TA indicator(s).

  • BRTX’s TA Score: 4 bullish, 6 bearish.
  • KYMR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both BRTX and KYMR are a bad buy in the short-term.

Price Growth

BRTX (@Biotechnology) experienced а -5.48% price change this week, while KYMR (@Biotechnology) price change was +6.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

BRTX is expected to report earnings on Mar 26, 2026.

KYMR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.57B) has a higher market cap than BRTX($11M). KYMR YTD gains are higher at: 57.917 vs. BRTX (-3.497). BRTX has higher annual earnings (EBITDA): -12.89M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. BRTX (7.38M). BRTX has less debt than KYMR: BRTX (42.4K) vs KYMR (85.7M). KYMR has higher revenues than BRTX: KYMR (44.7M) vs BRTX (605K).
BRTXKYMRBRTX / KYMR
Capitalization11M4.57B0%
EBITDA-12.89M-267.03M5%
Gain YTD-3.49757.917-6%
P/E RatioN/AN/A-
Revenue605K44.7M1%
Total Cash7.38M665M1%
Total Debt42.4K85.7M0%
FUNDAMENTALS RATINGS
BRTX: Fundamental Ratings
BRTX
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRTXKYMR
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 23 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 7 days ago
88%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BRTX
Daily Signal:
Gain/Loss:
KYMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAGHX29.320.30
+1.03%
Virtus KAR Health Sciences A
MEIAX52.820.21
+0.40%
MFS Value A
LBFIX60.36-0.05
-0.08%
ClearBridge Select I
JMNSX16.04-0.02
-0.12%
JPMorgan Research Market Neutral I
WRGCX21.90-0.03
-0.14%
Macquarie Small Cap Growth C

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with TCRT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
-2.13%
TCRT - BRTX
33%
Loosely correlated
+5.65%
RLAY - BRTX
30%
Poorly correlated
-1.91%
CDXS - BRTX
29%
Poorly correlated
+7.22%
GRCE - BRTX
28%
Poorly correlated
+0.97%
KYMR - BRTX
27%
Poorly correlated
+0.25%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.25%
NRIX - KYMR
64%
Loosely correlated
-5.37%
VERA - KYMR
60%
Loosely correlated
+4.61%
NUVL - KYMR
55%
Loosely correlated
+0.91%
CGON - KYMR
54%
Loosely correlated
+1.47%
IDYA - KYMR
54%
Loosely correlated
-0.19%
More